Digital Pathology Market is expected to reach $1,390 million by 2026
The digital pathology market accounted for $512 million in 2018, and is expected to reach $1,390 million by 2026, registering a CAGR of 13.3% from 2019 to 2026.
Digital pathology is defined as an image-based information setting enabled by computer technology that allows the management of information generated through a digital slide. Digital pathology solutions offer scrutiny & analysis of images on a computer, high-resolution sample scanning, and online storage of digital slides, which enable pathologists to cross examine slides without physical evidences.
Efficient cost of digital pathology products, ease of virtual transportation of slides, and high efficiency of digital pathology systems are the major factors that boost the growth of the global digital pathology market. In addition, growth in adoption of digital pathology as compared to conventional pathology diagnosis drives the market growth. On the other hand, barriers such as unclear reimbursement policies, dearth of skilled personnel, and unwillingness of older pathologists to adopt to new technology restrain the market growth. However, rise in initiatives toward commercialization of cost-efficient digital pathology systems is anticipated to offer profitable growth opportunities for service providers in the future.
The global digital pathology market is segmented on the basis of product, application, end user, and region. Based on product, the market is categorized into scanners, software, and storage & communication systems.
Based on application, it is classified into teleconsultation, disease diagnosis, drug discovery, and training & education. Depending on end user, the market is fragmented into educational, clinical, and pharma & biotech companies. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and, rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current global digital pathology market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
By Product
o Scanners
o Software
o Storage & Communication Systems
Application
o Teleconsultation
o Disease Diagnosis
o Drug Discovery
o Training & Education
By End User
o Educational
o Clinical
o Pharma & Biotech Companies
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
List of key players profiled in the report:
- 3DHISTECH Ltd.
- Danaher Corporation (Leica Microsystem)
- Glencoe Software, Inc.
- Hamamatsu Photonics K.K.
- Indica Labs Inc.
- Koninklijke Philips N.V.
- Nikon Corporation
- PerkinElmer Inc.
- Roche (Ventana Medical Systems, Inc.)
- Visiopharm A/S
LIST of OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
- GE Healthcare
- MicroSkan Technologies
- Objective Pathology Services
- Olympus Corporation
- Omnyx LLC
Visit More Information: Click Here
